Skip to main content

Table 4 Population prevalence of chronic disease (≥18 years) and proportion aware of condition

From: High prevalence of hypertension and of risk factors for non-communicable diseases (NCDs): a population based cross-sectional survey of NCDS and HIV infection in Northwestern Tanzania and Southern Uganda

Tanzania – Total respondents

Mwanza municipality (number = 175)

District towns (number = 344)

Rural (number = 576)

 

Weighted % (95 % CI)a

Unweighted Nb

Weighted % (95 % CI)a

Unweighted Nb

Weighted % (95 % CI)a

Unweighted Nb

HIV positivec

9.1 % (5.3–15.3)

15

10.3 % (6.5–15.8)

35

6.4 % (3.7–10.9)

37

 Previously diagnosedd

6.0 % (0.9–30.0)

1

34.5 % (16.9–57.7)

12

32.4 % (20.4–47.2)

12

 On treatmente

6.0 % (0.9 -30.0)

1

25.8 % (11.6-48.0)

9

28.7 % (17.1-44.0)

11

Hypertensionf

16.4 % (11.7–22.4)

29

16.8 % (12.6–21.9)

56

17.6 % (13.9–21.9)

107

 Previously diagnosed, on treatment and controlledd,g,h

3.7 % (0.6–18.5)

1

1.7 % (0.2–10.9)

1

0

0

 Previously diagnosed, on treatment and not controlledd,g,h

7.6 % (2.0–24.6)

2

5.4 % (1.5–17.6)

3

2.5 % (0.7–8.7 )

2

 Previously diagnosed and not on treatmentd,h

23.6 % (14.5–35.9)

7

10.4 % (4.7–21.6)

6

4.4 % (1.8–10.6)

4

 No previous diagnosish

65.2 % (50.4–77.6)

19

82.5 % (69.0–90.9)

46

93.1 % (82.9–97.4)

101

  Stage Ii

6.0 % (3.5–10.1)

11

10.7 % (7.4–15.3)

35

12.1 % (9.6–15.1)

74

  Stage IIi

8.8 % (5.1–14.8)

15

5.0 % (2.8–8.9 )

17

5.1 % (3.2–7.9 )

31

Diabetesj,k

1.9 % (0.7–5.0 )

3

1.5 % (0.6–3.6 )

5

0.6 % (0.1–2.8 )

3

 Previously diagnosedd

70.1 % (14.5–97.0)

2

82.4 % (40.3–97.0)

4

37.7 % (16.3–65.2)

1

 On treatmente

70.1 % (14.5–97.0)

2

41.2 % (7.8 -85.3)

2

37.7 % (16.3-65.2)

1

Heart failurel

3.3 % (1.7–6.4 )

6

1.4 % (0.8–2.5 )

5

4.5 % (3.2–6.2 )

22

 Previously diagnosedd

21.2 % (2.3–75.8)

1

0

0

0

0

COPD/asthmam,n

3.5 % (1.5–7.9 )

6

2.7 % (1.3–5.7 )

9

3.9 % (2.2–6.9 )

25

 Previously diagnosedd

0

0

11.8 % (1.3 -58.0)

1

8.5 % (2.2 -27.3)

2

 On treatmente

0

1

11.8 % (1.3 -58.0)

1

3.6 % (0.6 -19.8)

1

Epilepsyo

0.6 % (0.1–3.8 )

1

0.8 % (0.3–2.2 )

3

1.6 % (0.7–3.4 )

8

Any CD (NCDs and HIV infection)

29.5 % (20.2-40.9)

52

28.0 % (21.7-35.2)

95

29.1 % (25.1-33.4)

172

 More than one CD

4.7 % (2.3 -9.4 )

8

4.7 % (2.5 -8.5 )

17

4.1 % (2.3 -7.2 )

25

Any NCD

22.6 % (15.3-32.1)

40

20.8 % (15.3-27.7)

70

25.0 % (21.3-29.1)

148

 More than one NCD

2.9 % (1.3 -6.2 )

5

2.0 % (1.0 -4.0 )

7

2.8 % (1.4 -5.4 )

16

Uganda - Total respondents

Entebbe municipality (number = 206)

District towns (number = 278)

Rural (number = 432)

HIV positivec

12.2 % (9.4–15.7)

25

5.5 % (2.4–12.4)

24

11.6 % (8.0–16.6)

49

 Previously diagnosedd

40.0 % (22.5–60.5)

10

26.4 % (8.0–59.5)

8

51.9 % (34.8–68.5)

25

 On treatmente

36.0 % (19.5-56.6)

9

26.4 % (8.0 -59.5)

8

49.3 % (33.2-65.6)

24

Hypertensionf

22.3 % (16.2–30.0)

46

19.2 % (14.0–25.6)

49

26.3 % (23.0–29.9)

111

 Previously diagnosed, on treatment and controlledd,g,h

2.2 % (0.3–15.4)

1

3.4 % (0.5–20.8)

2

3.4 % (0.9–12.2)

3

 Previously diagnosed, on treatment and not controlledd,g,h

13.0 % (4.0–34.9)

6

12.8 % (4.3–32.3)

4

5.1 % (2.4–10.5)

5

 Previously diagnosed and not on treatmentd,h

15.2 % (7.4–28.9)

7

6.4 % (1.6–22.2)

2

11.9 % (7.1–19.2)

12

 No previous diagnosish

69.6 % (52.0–82.8)

32

77.3 % (59.2–88.9)

41

79.7 % (74.6–84.0)

91

  Stage Ii

12.1 % (7.3–19.3)

24

11.1 % (7.7–15.9)

26

16.9 % (14.3–19.9)

68

  Stage IIi

7.5 % (4.6–12.0)

15

5.4 % (2.8–10.4)

17

7.8 % (5.4–11.0)

35

Diabetesj,p

2.4 % (0.9–6.2 )

5

3.8 % (1.8–7.8 )

7

3.0 % (1.4–6.2 )

10

 Previously diagnosedd

80.0 % (34.6–96.8)

4

67.0 % (15.4–95.8)

5

40.0 % (22.3–60.8)

4

 On treatmente

80.0 % (34.6-96.8)

4

50.5 % (11.9-88.5)

4

30.0 % (15.2-50.6)

3

Heart failurel

9.2 % (5.5–15.1)

19

2.6 % (1.1–5.9 )

7

3.0 % (1.5–6.0 )

12

 Previously diagnosedd

5.3 % (0.7–30.9)

1

23.9 % (2.7–78.3)

1

0

0

COPD/asthmam,q

3.5 % (1.9–6.3 )

7

2.2 % (0.9–5.1 )

11

9.6 % (6.2–14.4 )

41

 Previously diagnosedd

0

0

0

0

3.3 % (0.5–18.3 )

1

 On treatmente

0

0

0

0

3.3 % (0.5–18.3 )

1

Epilepsyo,r

0

0

0

0

1.1 % (0.3–3.3 )

5

Any CD (NCDs and HIV infection)

39.3 % (35.4-43.4)

81

28.6 % (22.3-35.8)

84

44.7 % (38.9-50.6)

189

 More than one CD

7.3 % (5.5 -9.6 )

15

4.5 % (2.3 -8.4 )

12

8.9 % (6.3 -12.4)

38

Any NCD

31.1 % (26.7-35.8)

64

23.8 % (17.9-30.9)

64

36.7 % (32.8-40.8)

156

 More than one NCD

5.3 % (3.5 -8.0 )

11

3.8 % (1.8 -7.8 )

9

5.6 % (3.6 -8.6 )

23

  1. aWeighted estimates, adjusted for survey design with sampling weights applied. See footnote 1 of Table 1; bactual number of respondents, without sampling weights applied; 3HIV diagnosis missing for 8 participants from Mwanza municipality, 1 from Entebbe municipality, and for 1 rural participant in Uganda (majority refused blood test); dparticipants reported having been told by a doctor in the past 12 months that they have the condition; denominator is those diagnosed with the condition during the survey; eparticipants reported currently receiving medication for the condition; denominator is those diagnosed with the condition during the survey; fsystolic BP ≥140 and/or diastolic BP ≥90, in 3rd measurement at a single visit, or currently receiving drugs for high blood pressure. Missing for 1 participant from Mwanza municipality and 1 rural participant in Tanzania; gparticipants reported currently receiving drugs for high blood pressure; ‘controlled’ defined as systolic BP <140 and diastolic BP <90); hdenominator is N with hypertension; istage I: systolic BP ≥140 and <160 and/or diastolic BP ≥90 and <100. Stage II: systolic BP ≥160 and/or diastolic BP ≥100. Excludes participants currently receiving drugs for high blood pressure: 21 in Uganda and 9 Tanzania; jrandom blood glucose (RBG) >11.1, or RBG 7 to 11.1 and fasting blood glucose (FBG) ≥7 mmol/L, or currently receiving insulin or oral diabetes drugs in the last two weeks; kmissing for 3 participants from Mwanza municipality, 7 from district towns and for 12 rural participants (majority refused RBG or did not return for FBG test); lorthopnea or paroxysmal nocturnal dyspnea (PND) and at least 2/3 of edema, breathlessness on excersion (BOE) and heart rate (HR) >120, or orthopnea and PND and at least 1/3 of edema, BOE and HR >120; mFEV1/FVC <0.70; nCOPD/asthma diagnosis missing for 4 participants from Mwanza municipality, 8 from district towns and for 17 rural participants (mostly because test was contraindicated or participant unable to perform test); oreports having had a seizure in past 12 months, or currently taking medication for epilepsy; pmissing for 1 participant from district towns and for 2 rural participants; qCOPD/asthma diagnosis missing for 4 participant from Entebbe municipality, 9 from district towns and for 30 rural participants (majority were unable to perform the spirometry test); rmissing for one participant from Entebbe municipality. BP, blood pressure; CD, chronic disease; CI, confidence interval; COPD, chronic obstructive pulmonary disease; NCD, non-communicable disease
Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us